SAHMRI. Inspired research, better health for all.
Lifelong Health
29 April, 2016

Great news for clinical trials in South Australia

Lifelong Health

SAHMRI is delighted to welcome IDT CMAX to South Australia’s Health and Biomedical Precinct, Adelaide BioMed City. 

One of the first trials to be run in CMAX’s new, purpose-built clinical trials facility will be a gene therapy study looking at how peripheral arterial disease is treated. 

This collaborative gene therapy study will be overseen by SAHMRI’s Heart Health Theme Leader, Professor Steve Nicholls. It will also involve clinicians from The Queen Elizabeth Hospital and The Royal Adelaide Hospital. 

Clinical trials to benefit our community 

Professor Nicholls said that he is thrilled to be heading up this project. 

“Peripheral arterial disease is a circulatory problem where narrowed arteries reduce blood flow to the limbs,” he explained. “This can lead to really serious health complications, and in some cases, amputation of limbs.” 

“The beauty of clinical trials being conducted locally is that the benefits can flow back to the community directly. This means we can deliver improved treatments to patients, faster,” Professor Nicholls said.

You can't miss us

North Terrace
Adelaide 5000
South Australia

Postal address

PO Box 11060
Adelaide 5001
South Australia


Key partners

Founding memberFounding memberFounding memberFounding memberCapital supportMajor funderResearch partnerResearch partner

SAHMRI is located on the traditional lands of the Kaurna people.

The SAHMRI community acknowledges and pays respect to the Kaurna people as the traditional custodians of the Adelaide region. We also acknowledge the deep feelings of attachment and the relationship of the Kaurna people to their country. We pay our respects to the Kaurna peoples' ancestors and the living Kaurna people today.